Non-melanoma Skin Cancer Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape
The global non-melanoma skin cancer treatment market is expected to grow at a CAGR of around 8.3% during 2023-2030. This report on global non-melanoma skin cancer treatment market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global non-melanoma skin cancer treatment market by segmenting the market based on treatment type, indication, end use, and region. Also, detailed profiles of companies operating in the non-melanoma skin cancer treatment market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Increasing Cases of Skin Cancer
• Rising Adoption of Immunotherapy
• Drug Approvals
Market Challenges
• Side Effects due to Treatment
Historical & Forecast Period
Base Year: 2022
Historical Period: 2018-2022
Forecast Period: 2023-2030
Market by Treatment Type
• Chemotherapy
• Radiation Therapy
• Photodynamic Therapy
• Others
Market by Indication
• Basal Cell Carcinoma
• T-Cell Lymphoma
• Squamous Cell Carcinoma
• Others
Market by End Use
• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers
• Others
Market by Region
• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. Global Non-melanoma Skin Cancer Treatment Market
- 3.1. Introduction
- 3.2. Market Drives
- 3.3. Market Challenges
- 4. Global Non-melanoma Skin Cancer Treatment Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Size
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 5. Global Non-melanoma Skin Cancer Treatment Market by Treatment Type
- 5.1. Introduction
- 5.2. Chemotherapy
- 5.3. Radiation Therapy
- 5.4. Photodynamic Therapy
- 5.5. Others
- 6. Global Non-melanoma Skin Cancer Treatment Market by Indication
- 6.1. Introduction
- 6.2. Basal Cell Carcinoma
- 6.3. T-Cell Lymphoma
- 6.4. Squamous Cell Carcinoma
- 6.5. Others
- 7. Global Non-melanoma Skin Cancer Treatment Market by End Use
- 7.1. Introduction
- 7.2. Hospitals
- 7.3. Specialty Clinics
- 7.4. Ambulatory Surgery Centers
- 7.5. Others
- 8. Global Non-melanoma Skin Cancer Treatment Market by Region
- 8.1. Introduction
- 8.2. Europe
- 8.2.1. Germany
- 8.2.2. United Kingdom
- 8.2.3. France
- 8.2.4. Italy
- 8.2.5. Spain
- 8.2.6. Russia
- 8.2.7. Netherlands
- 8.2.8. Rest of the Europe
- 8.3. North America
- 8.3.1. United States
- 8.3.2. Canada
- 8.4. Asia Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. South Korea
- 8.4.5. Australia
- 8.4.6. Indonesia
- 8.4.7. Rest of the Asia Pacific
- 8.5. Latin America
- 8.5.1. Mexico
- 8.5.2. Brazil
- 8.5.3. Argentina
- 8.5.4. Rest of Latin America
- 8.6. Middle East & Africa
- 8.6.1. Saudi Arabia
- 8.6.2. Turkey
- 8.6.3. Iran
- 8.6.4. United Arab Emirates
- 8.6.5. Rest of Middle East & Africa
- 9. SWOT Analysis
- 10. Porter’s Five Forces
- 11. Market Value Chain Analysis
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Company Profiles
- 12.2.1. Almirall S.A.
- 12.2.2. Amgen Inc.
- 12.2.3. Boehringer Ingelheim GmbH
- 12.2.4. Bristol-Myers Squibb Company
- 12.2.5. Elekta AB
- 12.2.6. Eli Lilly and Company
- 12.2.7. F. Hoffmann-La Roche AG
- 12.2.8. GlaxoSmithKline Plc
- 12.2.9. Icad Inc.
- 12.2.10. Merck & Co. Inc.
- 12.2.11. Novartis AG
- 12.2.12. Pfizer
- 12.2.13. Regeneron Pharmaceuticals, Inc.
- 12.2.14. Sun Pharmaceutical Industries Limited
- 12.2.15. Varian Medical Systems Inc.
- List of Figures
- Figure 1: Global Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 2: Global Non-melanoma Skin Cancer Treatment Market by Treatment Type, 2022
- Figure 3: Global Non-melanoma Skin Cancer Treatment Market by Indication, 2022
- Figure 4: Global Non-melanoma Skin Cancer Treatment Market by End Use, 2022
- Figure 5: Global Non-melanoma Skin Cancer Treatment Market by Region, 2022
- Figure 6: Global Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 7: Global Non-melanoma Skin Cancer Treatment Market by Product (in %), 2022 & 2030
- Figure 8: Global Non-melanoma Skin Cancer Chemotherapy Market (in US$ Million), 2018-2022
- Figure 9: Global Non-melanoma Skin Cancer Chemotherapy Market (in US$ Million), 2023-2030
- Figure 10: Global Non-melanoma Skin Cancer Radiation Therapy Market (in US$ Million), 2018-2022
- Figure 11: Global Non-melanoma Skin Cancer Radiation Therapy Market (in US$ Million), 2023-2030
- Figure 12: Global Non-melanoma Skin Cancer Photodynamic Therapy Market (in US$ Million), 2018-2022
- Figure 13: Global Non-melanoma Skin Cancer Photodynamic Therapy Market (in US$ Million), 2023-2030
- Figure 14: Global Non-melanoma Skin Cancer Other Therapies Market (in US$ Million), 2018-2022
- Figure 15: Global Non-melanoma Skin Cancer Other Therapies Market (in US$ Million), 2023-2030
- Figure 16: Global Non-melanoma Skin Cancer Treatment Market by Indication (in %), 2022 & 2030
- Figure 17: Global Basal Cell Carcinoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 18: Global Basal Cell Carcinoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 19: Global T-Cell Lymphoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 20: Global T-Cell Lymphoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 21: Global Squamous Cell Carcinoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 22: Global Squamous Cell Carcinoma Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 23: Global Other Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 24: Global Other Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 25: Global Non-melanoma Skin Cancer Treatment Market by End Use (in %), 2022 & 2030
- Figure 26: Global Hospitals Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 27: Global Hospitals Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 28: Global Specialty Clinics Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 29: Global Specialty Clinics Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 30: Global ASCs Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 31: Global ASCs Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 32: Global Other Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 33: Global Other Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 34: Global Non-melanoma Skin Cancer Treatment Market by Region (in %), 2022 & 2030
- Figure 35: Europe Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 36: Europe Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 37: Europe Non-melanoma Skin Cancer Treatment Market by Country (in %), 2022 & 2030
- Figure 38: Germany Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 39: United Kingdom Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 40: France Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 41: Italy Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 42: Spain Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 43: Russia Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 44: Netherlands Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 45: Rest of Europe Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 46: North America Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 47: North America Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 48: North America Non-melanoma Skin Cancer Treatment Market by Country (in %), 2022 & 2030
- Figure 49: United States Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 50: Canada Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 51: Asia Pacific Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 52: Asia Pacific Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 53: Asia Pacific Non-melanoma Skin Cancer Treatment Market by Country (in %), 2022 & 2030
- Figure 54: China Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 55: Japan Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 56: India Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 57: South Korea Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 58: Australia Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 59: Indonesia Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 60: Rest of Asia Pacific Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 61: Latin America Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 62: Latin America Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 63: Latin America Non-melanoma Skin Cancer Treatment Market by Country (in %), 2022 & 2030
- Figure 64: Mexico Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 65: Brazil Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 66: Argentina Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 67: Rest of Latin America Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 68: Middle East & Africa Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2022
- Figure 69: Middle East & Africa Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2023-2030
- Figure 70: Middle East & Africa Non-melanoma Skin Cancer Treatment Market by Country (in %), 2022 & 2030
- Figure 71: Saudi Arabia Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 72: Turkey Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 73: Iran Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 74: UAE Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 75: Rest of Middle East and Africa Non-melanoma Skin Cancer Treatment Market (in US$ Million), 2018-2030
- Figure 76: Market Value Chain
- List of Tables
- Table 1: Global Non-melanoma Skin Cancer Treatment Market Portraiture
- Table 2: Global Non-melanoma Skin Cancer Treatment Market by Treatment Type (in US$ Million), 2022 & 2030
- Table 3: Global Non-melanoma Skin Cancer Treatment Market by Indication (in US$ Million), 2022 & 2030
- Table 4: Global Non-melanoma Skin Cancer Treatment Market by End Use (in US$ Million), 2022 & 2030
- Table 5: Global Non-melanoma Skin Cancer Treatment Market by Region (in US$ Million), 2022 & 2030
- Table 6: Europe Non-melanoma Skin Cancer Treatment Market by Country (in US$ Million), 2022 & 2030
- Table 7: North America Non-melanoma Skin Cancer Treatment Market by Country (in US$ Million), 2022 & 2030
- Table 8: Asia Pacific Non-melanoma Skin Cancer Treatment Market by Country (in US$ Million), 2022 & 2030
- Table 9: Latin America Non-melanoma Skin Cancer Treatment Market by Country (in US$ Million), 2022 & 2030
- Table 10: Middle East & Africa Non-melanoma Skin Cancer Treatment Market by Country (in US$ Million), 2022 & 2030
- Table 11: List of Key Players